Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery
2007 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial
2012
Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery
2007
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Parenteral Anticoagulants
2012 Standout
Duration of Red-Cell Storage and Complications after Cardiac Surgery
2008 Standout
Clinical practice guidelines for the use of noninvasive positive-pressure ventilation and noninvasive continuous positive airway pressure in the acute care setting
2011
Pneumonectomy due to lung cancer results in a more pronounced activation of coagulation system than lobectomy
2009
Aprotinin counterbalances an increased risk of peri-operative haemorrhage in CABG patients pre-treated with Aspirin
1998
Aprotinin Versus Lysine Analogues: The Debate Continues
1998
Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation
2017 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Aprotinin and tranexamic acid for high transfusion risk cardiac surgery
2000
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Effects of aprotinin on blood loss, heparin monitoring tests, and heparin doses in patients undergoing coronary artery bypass surgery
1995
Perioperative Management of Antithrombotic Therapy
2012 Standout
High-Dose ϵ-Aminocaproic Acid Versus Aprotinin: Antifibrinolytic Efficacy in First-Time Coronary Operations
1998
Non-invasive ventilation in postoperative patients: a systematic review
2011
Operative Treatment of Coronary Atherosclerosis
2008
Blood use in elective surgery: the Austrian benchmark study
2007
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose Regimens
1996
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Global epidemiology and outcomes of acute kidney injury
2018 Standout
Liver fatty acid-binding protein: An early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors
2005
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Activity‐based costs of blood transfusions in surgical patients at four hospitals
2009 Standout
Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass
2005
The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis
2008
Low-dose and high-dose aprotinin improve hemostasis in coronary operations
1996
Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial
2009
Restoration of the Normal Coagulation Process: Advances in Therapies to Antagonize Heparin
1996
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting*
2006
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
2011 Standout
Effects of Midazolam on Brain Injury After Transient Focal Cerebral Ischemia in Rats*
2009
Bladder cancer
2016 Standout
The Risk Associated with Aprotinin in Cardiac Surgery
2006
A Trial of Intraoperative Low-Tidal-Volume Ventilation in Abdominal Surgery
2013 Standout
Ascending Thoracic Aneurysms Are Associated With Decreased Systemic Atherosclerosis
2005
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature
1998
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
2009 Standout
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers
2016
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
1999
Influence of High- and Low-Dose Aprotinin on Activation of Hemostasis in Open Heart Operations
1998
A randomized controlled pilot study of adherence to transfusion strategies in cardiac surgery
2011
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Update on Tumor Cell Procoagulant Factors
2001
Prevention and Treatment of Major Blood Loss
2007
Fibrinolysis-adjusted perioperative low-dose aprotinin reduces blood loss in bypass operations
1998
Familial Thoracic Aortic Aneurysms and Dissections—Incidence, Modes of Inheritance, and Phenotypic Patterns
2006
The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery
2005
Hematocrit on Cardiopulmonary Bypass and Outcome After Coronary Surgery in Nontransfused Patients
2009
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
1998
Update on management of diabetic foot ulcers
2018 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Anticoagulation Monitoring during Cardiac Surgery
1999
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
Acute Kidney Injury and Chronic Kidney Disease After Cardiac Surgery
2008
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery
2013
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial
2011 Standout
Is ε-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery?
1999
International consensus statement on the peri‐operative management of anaemia and iron deficiency
2016 Standout
Interventions for protecting renal function in the perioperative period
2013
Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations
2016
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy
2001
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting
1995
BMI Is an Independent Preoperative Predictor of Intraoperative Transfusion and Postoperative Chest-Tube Output
2013
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Postoperative Noninvasive Ventilation
2010
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 Standout
Procalcitonin as an Acute Phase Marker
2001
Part 14: Pediatric Advanced Life Support
2010 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
Cellular and molecular characterization of Ca2+ currents in acutely isolated, adult rat neostriatal neurons
1994
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of P. Feindt being referenced
Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study
2006
Platelet Function Analyzer (PFA-100) as a Useful Tool for the Prediction of Transfusion Requirements during Aortic Valve Replacement
2011
Celite and Kaolin Produce Differing Activated Clotting Times during Cardiopulmonary Bypass under Aprotinin Therapy
1994
Post-Perfusion Syndrome and Disturbed Microcirculation After Cardiac Surgery: the Role of Angiotensin-Converting-Enzyme Inhibitors
1999
Prophylactic Nasal Continuous Positive Airway Pressure Following Cardiac Surgery Protects From Postoperative Pulmonary Complications
2008
Gene Expression Profiles in the Acutely Dissected Human Aorta
2002
Effects of high-dose aprotinin on renal function in aortocoronary bypass grafting
1995
Activated Clotting Time, Anticoagulation, Use of Heparin, and Thrombin Activation during Extra-corporeal Circulation: Changes under Aprotinin Therapy
1993
Intracellular N-methyl-d-glucamine modifies the kinetics and voltage-dependence of the calcium current in guinea pig ventricular heart cells
1988
Diagnostic Value of Procalcitonin: the Influence of Cardiopulmonary Bypass, Aprotinin, SIRS, and Sepsis
1998
Is there a phase of hypercoagulability when aprotinin is usedin cardiac surgery?
1994
Cardiopulmonary bypass: Evidence or experience based?
2002
Neurological Complications After Cardiac Surgery: Risk Factors and Correlation to the Surgical Procedure
2005
Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting
2001
The Role of Protein C as an Inhibitor of Blood Clotting During Extracorporeal Circulation
1991
Predictors of Homologous Blood Transfusion for Patients Undergoing Open Heart Surgery
2003
The use of autologous platelet gel (APG) for high-risk patients in cardiac surgery — is it beneficial?
2009
Markers of Activated Hemostasis and Fibrinolysis in Patients with Pulmonary Malignancies
2000
Impact of mitral valve repair in patients with mitral regurgitation undergoing coronary artery bypass grafting.
2010
Impact of mitral valve repair in patients with mitral regurgitation undergoing coronary artery bypass grafting
2009
Aortic valve replacement in octogenarians: outcome and predictors of complications.
2011